Search research articles
Contact Us
Filters
Showing results (291-300 of 306) with videos related to
Page
of 31
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 26, 2011
Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus
Yasuji Arase, Fumitaka Suzuki, Mariko Kobayashi, et al.
The American Journal of Gastroenterology
|
February 22, 2022
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase
Tai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.
Journal of Medical Virology
|
January 21, 2010
Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus
Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Hepatology (Baltimore, Md.)
|
March 20, 2025
Higher level of Hepatitis B Surface antigen associated with delayed development of hepatocellular carcinoma in immune-tolerant patients
Tai-Chung Tseng, Tetsuya Hosaka, Mei-Hung Pan, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 17, 2020
Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease
Yorinari Ochiai, Yusuke Kawamura, Masahiro Kobayashi, et al.
Liver Cancer
|
June 24, 2026
Nivolumab plus Ipilimumab versus Lenvatinib or Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: CheckMate 9DW Japanese Subgroup Analysis
Masatoshi Kudo, Atsushi Hiraoka, Kazushi Numata, et al.
Oncology
|
November 18, 2020
Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment
Daiki Yamashige, Yusuke Kawamura, Masahiro Kobayashi, et al.
Liver Cancer
|
January 14, 2021
Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma
Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
The Lancet. Gastroenterology & Hepatology
|
May 16, 2020
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye, Biyao Zou, Yee Hui Yeo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 20, 2011
Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients
Yasuji Arase, Mariko Kobayashi, Fumitaka Suzuki, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 306) with videos related to
Sort By:
Page
of 31
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 26, 2011
Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus
Yasuji Arase, Fumitaka Suzuki, Mariko Kobayashi, et al.
The American Journal of Gastroenterology
|
February 22, 2022
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase
Tai-Chung Tseng, Tetsuya Hosaka, Chun-Jen Liu, et al.
Journal of Medical Virology
|
January 21, 2010
Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus
Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.
Hepatology (Baltimore, Md.)
|
March 20, 2025
Higher level of Hepatitis B Surface antigen associated with delayed development of hepatocellular carcinoma in immune-tolerant patients
Tai-Chung Tseng, Tetsuya Hosaka, Mei-Hung Pan, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 17, 2020
Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease
Yorinari Ochiai, Yusuke Kawamura, Masahiro Kobayashi, et al.
Liver Cancer
|
June 24, 2026
Nivolumab plus Ipilimumab versus Lenvatinib or Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: CheckMate 9DW Japanese Subgroup Analysis
Masatoshi Kudo, Atsushi Hiraoka, Kazushi Numata, et al.
Oncology
|
November 18, 2020
Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment
Daiki Yamashige, Yusuke Kawamura, Masahiro Kobayashi, et al.
Liver Cancer
|
January 14, 2021
Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma
Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, et al.
The Lancet. Gastroenterology & Hepatology
|
May 16, 2020
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye, Biyao Zou, Yee Hui Yeo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
December 20, 2011
Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients
Yasuji Arase, Mariko Kobayashi, Fumitaka Suzuki, et al.
Page
of 31